Elisa F. Long, Ph.D.
Affiliations: | 2008 | Stanford University, Palo Alto, CA |
Area:
Operations Research, Public HealthGoogle:
"Elisa Long"Cross-listing: PHTree
Parents
Sign in to add mentorMargaret L. Brandeau | grad student | 2008 | Stanford | |
(Economic analysis of preventive and therapeutic HIV interventions.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zelenev A, Long E, Bazazi AR, et al. (2016) The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling. The International Journal On Drug Policy. 37: 98-106 |
Gilbert JA, Long EF, Brooks RP, et al. (2015) Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa. Plos One. 10: e0126267 |
VanDeusen A, Paintsil E, Agyarko-Poku T, et al. (2015) Cost effectiveness of option B plus for prevention of mother-to-child transmission of HIV in resource-limited countries: evidence from Kumasi, Ghana. Bmc Infectious Diseases. 15: 130 |
Song DL, Altice FL, Copenhaver MM, et al. (2015) Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United States. Plos One. 10: e0116694 |
Long EF, Mandalia R, Mandalia S, et al. (2014) Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom. Plos One. 9: e95735 |
Alistar SS, Long EF, Brandeau ML, et al. (2014) HIV epidemic control-a model for optimal allocation of prevention and treatment resources. Health Care Management Science. 17: 162-81 |
Long EF, Stavert RR. (2013) Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. Journal of General Internal Medicine. 28: 1294-301 |
Eaton JW, Johnson LF, Salomon JA, et al. (2012) HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. Plos Medicine. 9: e1001245 |
Long EF. (2011) HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis. Plos One. 6: e27625 |
Juusola JL, Brandeau ML, Long EF, et al. (2011) The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA. Aids (London, England). 25: 1779-87 |